Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy

Cancer

Volumn 88, Issue 10, 2000, Pages 2350-2356

  Madajewicz, Stefan ^a,c   Chowhan, Naveed ^a   Tfayli, Arafat ^a   Roque, Clemente ^a   Meek, Allen ^a   Davis, Raphael ^a   Wolf, Walter ^b   Cabahug, Corazon ^a   Roche, Patricia ^a   Manzione, James ^a   Iliya, Affif ^a   Shady, Magdy ^a   Hentschel, Patricia ^a   Atkins, Harold ^a   Braun, Alex ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Brain tumors; Chemotherapy; Glioblastoma; Glioma; Intraarterial

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GLIOBLASTOMA; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 17644444008     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2350::AID-CNCR20>3.0.CO;2-R     Document Type: Article

References (12)

1. Salcman M. Glioblastoma and malignant astrocytoma. In: Kaye A, Laws ER Jr., editors. Brain tumors New York: Churchill Livingstone, 1995:449-78.
2. Chang SM, Prados MD. Chemotherapy for gliomas. In: American Society of Clinical Oncology Educational Book. 1996:258-65.
3. Stewart D. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J Neurooncol 1994;20:1211-59.
4. Manzione J, Madajewicz S, Roque C, Roche P, Shindo M. Regional-therapy of high grade astrocytomas. Semin Int Rad 1998;15(4):365-71.
5. Madajewicz S, Chowhan N, Iliya A, Roque C, Beaton R, Davis R, et al. Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumors. Cancer 1991;67:2844-9.
6. Tfayli A, Hentschel P, Madajewicz S, Manzione J, Chowhan N, Davis R, et al. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 1999;42:73-7.
7. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995;45:8-30.
8. rd, Loeffler JS, et al. High-grade astrocytomas. Neurol Clin 1995; 13:875-96.
9. Fine HA, Dear KB, Loeffler JS, Block PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993; 71:2585-97.
10. Mortimer JE, Crowley J, Eyre H, Weiden P, Eltringham J, Stuckey WJ. A phase II randomized study comparing sequential and combined intraarterial cisplatin and radiation therapy in primary brain tumors. A Southwest Oncology Group Study. Cancer 1992;69:1220-3.
11. Dropcho EJ, Rosenfeld SS, Morawetz RB, Vitek J, Brothers M, Gorum T, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The CNS Cancer Consortium. J Clin Oncol 1992;10:452-8.
12. Spigelman MK, Zapulla RA, Stranchen JA, Feuer EJ, Johnson J, Goldsmith SJ, et al. Etoposide-induced blood-brain barrier disruption in rats: duration of opening and histological sequelae. Cancer Res 1986;46:1453-7.